Challenges to India's Pharmaceutical Patent Laws

An Indian Supreme Court decision about variants of existing compounds could affect access to affordable drugs. The Indian Supreme Court will soon hear final arguments in a challenge by the pharmaceutical company Novartis against the Indian Patent Office's (IPO) rejection of a patent for the leu...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	Science (American Association for the Advancement of Science) 2012-07, Vol.337 (6093), p.414-415
Hauptverfasser:	Sampat, Bhaven N., Shadlen, Kenneth C., Amin, Tahir M.
Format:	Artikel
Sprache:	eng
Schlagworte:	Business Business innovation Developing countries Drugs Evergreening Health outcomes Intellectual property Intellectual property law LDCs Leukemia Molecules Patent law Pharmaceutical industry Pharmaceutical preparations POLICY FORUM Public health
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Schreiben Sie den ersten Kommentar!